Survey reveals most Americans are uninformed about HPV A vaccine can prevent cancer—most people don’t take it

CDC updates childhood vaccine recommendations

Jim O’Neill, acting director of the Centers for Disease Control and Prevention, announced that he has signed off on a slew of recommendations that change the childhood vaccination schedule.

October 10, 2025

Vol.51 No.37

By Claire Marie Porter

Clinical Roundup

OSUCCC–James researchers are using AI to better predict, diagnose lobular cancer

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at the Ohio State University Comprehensive Cancer Center is using artificial intelligence to devise new ways of predicting which patients will develop an aggressive and difficult-to-detect form of breast cancer called lobular cancer, which represents one in every 10 breast cancers diagnosed in the United States.

October 10, 2025

Vol.51 No.37

Cancer Policy

Ousted CDC director testifies before Senate HELP Committee

Ousted from her position as director of the Centers for Disease Control and Prevention less than a month after her confirmation, Susan Monarez has now had the chance to tell her side of the story before Congress.

September 19, 2025

Vol.51 No.34

By Claire Marie Porter

Cancer Policy

CDC’s ACIP makes changes to childhood vaccine recommendations in first meeting since Monarez’s ouster

At a two-day meeting, the Center for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted 8-3 to change the current recommendations that allow children under age 4 to receive the MMRV vaccine, a combination shot for measles, mumps, rubella and chickenpox (or varicella).

September 19, 2025

Vol.51 No.34

By Claire Marie Porter

Clinical Roundup

Checkpoint therapy breakthrough sparks new vaccine

Immune-checkpoint therapy, which attempts to harness a patient’s own immune system to fight cancer, has revolutionized cancer care over the past two decades.

September 12, 2025

Vol.51 No.33

Clinical Roundup

Preclinical study reveals how HPV reprograms immune cells to help cancer grow

The most common cancer-causing strain of human papillomavirus, HPV16, undermines the body’s defenses by reprogramming immune cells surrounding the tumor, according to a preclinical study from researchers at the Keck School of Medicine of USC. In mice, blocking this process boosted the ability of experimental treatments for HPV to eliminate cancer cells.

September 12, 2025

Vol.51 No.33

Survey reveals most Americans are uninformed about HPV

A vaccine can prevent cancer—most people don’t take it

YOU MAY BE INTERESTED IN

CDC updates childhood vaccine recommendations

OSUCCC–James researchers are using AI to better predict, diagnose lobular cancer

Ousted CDC director testifies before Senate HELP Committee

CDC’s ACIP makes changes to childhood vaccine recommendations in first meeting since Monarez’s ouster

Checkpoint therapy breakthrough sparks new vaccine

Preclinical study reveals how HPV reprograms immune cells to help cancer grow

Renew today!

Subscriber content

Never miss an issue!

Login